Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration
- PMID: 2557795
- DOI: 10.1002/ana.410260613
Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration
Abstract
A topographical immunocytochemical analysis was performed on the substantia nigra from patients with idiopathic Parkinson's disease and striatonigral degeneration. Antibodies to tyrosine hydroxylase, a marker for nigrostriatal dopaminergic neurons, and to calcineurin, a marker for striatonigral projection fibers, were used in this study. There was a marked depletion of dopaminergic neurons in the substantia nigra of parkinsonian patients compared with control subjects, the reduction being greater in the lateral portion than in the medial portion (p less than 0.001). Calcineurin immunoreactivity was densely distributed throughout the substantia nigra of patients with Parkinson's disease and control subjects. The numbers of dopaminergic neurons and of calcineurin-immunoreactive fibers were markedly reduced in the lateral portion of the substantia nigra in all patients with striatonigral degeneration. Our results suggest that many symptoms of these two diseases may be due to disruption of the functions of the putamen and the lateral portion of the substantia nigra, which have dense reciprocal connections as part of the dopamine-related nigrostriatal loop.
Similar articles
-
Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in parkinsonism-dementia complex on Guam in comparison with those in Parkinson's and Alzheimer's diseases.Ann Neurol. 1990 May;27(5):520-7. doi: 10.1002/ana.410270511. Ann Neurol. 1990. PMID: 1694418
-
Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra.Ann Neurol. 1989 Jul;26(1):47-50. doi: 10.1002/ana.410260107. Ann Neurol. 1989. PMID: 2549846
-
Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.Neurosci Lett. 2007 Aug 9;423(1):12-7. doi: 10.1016/j.neulet.2007.06.031. Epub 2007 Jun 28. Neurosci Lett. 2007. PMID: 17644250
-
Striatonigral degeneration. A case report and a review of the literature.Clin Neurol Neurosurg. 1988;90(2):121-4. doi: 10.1016/s0303-8467(88)80030-1. Clin Neurol Neurosurg. 1988. PMID: 3061696 Review.
-
Substantia nigra and Parkinson's disease: a brief history of their long and intimate relationship.Can J Neurol Sci. 2010 May;37(3):313-9. doi: 10.1017/s0317167100010209. Can J Neurol Sci. 2010. PMID: 20481265 Review.
Cited by
-
Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):737-41. doi: 10.1136/jnnp.67.6.737. J Neurol Neurosurg Psychiatry. 1999. PMID: 10567489 Free PMC article.
-
Altered parabrachial nucleus nociceptive processing may underlie central pain in Parkinson's disease.NPJ Parkinsons Dis. 2023 May 26;9(1):78. doi: 10.1038/s41531-023-00516-x. NPJ Parkinsons Dis. 2023. PMID: 37236965 Free PMC article.
-
Early-stage [123I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease.Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):689-95. doi: 10.1007/s00259-004-1733-4. Epub 2005 Jan 29. Eur J Nucl Med Mol Imaging. 2005. PMID: 15682332
-
Striatonigral involvement following transient focal cerebral ischemia in the rats: an immunohistochemical study on a reversible ischemia model.Acta Neuropathol. 1993;85(5):515-20. doi: 10.1007/BF00230491. Acta Neuropathol. 1993. PMID: 8388149
-
[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):133-40. doi: 10.1136/jnnp.62.2.133. J Neurol Neurosurg Psychiatry. 1997. PMID: 9048712 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources